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Repair of tetralogy of Fallot (TOF) has shown excellent outcomes. However it leaves varying degrees 
of residual hemodynamic impairment, with severe pulmonary stenosis (PS) and free pulmonary 
regurgitation (PR) at both ends of the spectrum. Since the 1980s, studies evaluating late outcomes 
after TOF repair revealed the adverse impacts of residual chronic PR on RV volume and function; 
thus, a turnaround of operational strategies has occurred from aggressive RV outflow tract (RVOT) 
reconstruction for complete relief of RVOT obstruction to conservative RVOT reconstruction for limiting 
PR. This transformation has raised the question of how much residual PS after conservative RVOT 
reconstruction is acceptable. Besides, as pulmonary valve replacement (PVR) increases in patients 
with RV deterioration from residual PR, there is concern regarding when it should be performed. 
Regarding residual PS, several studies revealed that PS in addition to PR was associated with less PR 
and a small RV volume. This suggests that PS combined with PR makes RV diastolic property to protect 
against dilatation through RV hypertrophy and supports conservative RVOT enlargement despite 
residual PS. Also, several studies have revealed the pre-PVR threshold of RV parameters for the 
normalization of RV volume and function after PVR, and based on these results, the indications for PVR 
have been revised. Although there is no established strategy, better understanding of RV mechanics, 
development of new surgical and interventional techniques, and evidence for the effect of PVR on RV 
reverse remodeling and its late outcome will aid us to optimize the management of TOF.  
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Introduction 
Tetralogy of Fallot (TOF) is the most common form of cyanotic congenital heart disease 
and has been successfully repaired since the first intracardiac repair in 1954
1). However, 
although the repair of TOF has showed excellent outcomes (i.e., a 20-year survival rate 
of approximately 90%), it leaves varying degrees of residual hemodynamic impairment. 
Varying degrees of pulmonary regurgitation (PR) and/or pulmonary stenosis (PS) remain 
in the majority of patients after right ventricular outflow tract (RVOT) reconstruction, 
and severe PS and free PR are at both ends of the spectrum in residual hemodynamic 
impairment.
In the early period, the preferred surgical techniques were aggressive RVOT enlargement 
using a transannular patch, pulmonary velvectomy, and large right ventriculotomy for 
the complete relief of RVOT obstruction despite resultant severe PR because PR was 
thought to be a benign lesion. However, since the 1980s, late outcome studies revealed http://dx.doi.org/10.3345/kjp.2013.56.6.235
Byung WY and Han KP • PS and PR after TOF repair
236
that chronic PR can lead to right ventricular (RV) volume 
overload and dysfunction, resulting in an increase in long-term 
morbidity and mortality
2-4). A remarkable turnaround of the 
technique used in TOF repair has occurred, thus currently most 
centers employ surgical strategies that preserve the pulmonary 
annulus and valve in order to limit PR. Thereafter, the residual 
PS that results from conservative RVOT enlargement and valve-
sparing techniques is confronted and the acceptable amount of 
residual PS is concerned. On the other hand, as pulmonary valve 
replacement (PVR) is increasing in patients with RV deterioration 
from residual PR after TOF repair, there is concern regarding 
when PVR should be performed. This article reviews the main 
issues for residual PR and PS after the repair of TOF in order to 
optimize the surgical strategies in these patients.
PR: what are the major determinants and risk factors?
During the last 2 decades, it has been well recognized that 
patients with repaired TOF are at risk for exercise intolerance, 
right heart failure, life-threatening ventricular arrhythmia, and 
sudden death at late follow-up owing to residual chronic PR
5-
9). Numerous studies have shown a close relationship between 
the degree of PR and RV dimensions and between the RV 
dimensions and RV ejection fraction (EF) (Fig. 1)
10-13), although 
the degree of PR has no direct relationship with the RV EF. 
In addition, left ventricular (LV) function deteriorates with 
progressive RV dysfunction through interventricular interaction, 
the so-called “reversed Bernheim effect” (Fig. 2)
5,10).
Considering the major determinants of PR, the hemodynamic 
mechanics of PR are somewhat different from those of aortic 
regurgitation (AR). The major determinants of semilunar valve 
regurgitation are the size of the regurgitant orifice, the diastolic 
pressure gradient between the great artery and ventricle, the 
ventricular diastolic compliance, and the duration of diastole
14). 
While the diastolic pressure gradient between the aorta and 
LV is an overwhelming determinant in AR, all the variables 
may work together in determining the degree of PR without 
a dominant factor. Because of the low pressure and low 
impedance in the pulmonary vasculature, other factors play 
a relatively important role. Under this circumstance, we can 
understand the pathophysiology and time course of chronic PR 
(Fig. 3)
15). Low compliance of a hypertrophied RV early after 
TOF repair and the relatively high heart rate in young age (short 
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Fig. 1. Right ventricular (RV) mechanics after repair of tetralogy of Fallot. (A, B) Correlations between the 
pulmonary regurgitation fraction and RV volume. (C, D) Correlations between the RV volume and function. 
RVEDVi, right ventricular end-diastolic volume index; RVESVi, right ventricular end-systolic volume index; 
RV EF, right ventricular ejection fraction. Adapted from Yoo et al. J Thorac Cardiovasc Surg 2012;143:1299-
304
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duration of diastole) may limit PR despite the large regurgitant 
orifice, and changes in these factors at late follow-up may 
augment PR in long-term survivors. Over a long period after 
the elimination of RVOT obstruction, decreases of RV mass and 
RV dilatation by PR develop and cause a decrease in the mass/
volume ratio of RV, an increase in RV wall stress, and finally RV 
dysfunction. Thus, generally, patients with repaired TOF tolerate 
chronic PR for decades, and the development of symptoms and 
mortality exponentially increase after the third postoperative 
decade
16,17).
However, deterioration of the RV caused by PR is not consis-
tent in patients with repaired TOF. Some patients have shown 
severely progressive RV dilatation and dysfunction with 
time, while other patients have tolerated PR well, resulting in 
preserved RV volume and function. What accounts for this 
difference in patients after TOF repair? Many previous studies 
have tried to find out the risk factors for RV deterioration 
caused by PR. However, it is not always easy to demonstrate 
the clear impact of related factors on RV mechanics because 
of confounding factors from anatomic diversity, advances in 
surgery and treatment, residual or acquired hemodynamic 
impairment after repair, and combined arrhythmia. Nonetheless, 
some studies have revealed that palliative shunt operation, 
age at the time of the repair, the use of a transannular patch, 
and aneurysmal dilatation of RVOT have adverse effects on 
RV volume and function
4,5,18-21). These results led us to develop 
several modified techniques of conservative RVOT enlargement 
and valve sparing in order to avoid using a transannular patch 
and developing aneurismal dilatation of the RVOT
22,23), although 
the late outcome of these techniques is not yet demonstrated. 
However, debates for other factors have not been conclusive. 
A recent study revealed that previous palliative shunt history 
was not a risk factor for PVR
24). Regarding age at the time of the 
repair, some reports suggested that early repair (i.e., <6 months 
of age) may not be beneficial because of a more common 
transannular patch and lesser restrictive physiology repair
25), and 
others suggested that repair after 1 year of age was correlated 
with a lower quality of life
5,26).
Restrictive RV physiology (i.e., the condition of decreased RV 
diastolic compliance) has been recognized to limit the adverse 
effects of PR, resulting in a smaller RV size, improved exercise 
performance, and a lowered propensity to arrhythmia
8,27,28). 
However, some cardiac magnetic resonance (CMR) imaging 
studies have disagreed with the beneficial effect of restrictive 
physiology
12,29,30). Although the reason of this discrepancy 
is not clear, it is suggested that the difference in defining 
restrictive physiology between CMR imaging and Doppler 
echocardiography may have caused the inconsistent results
31). 
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Fig. 2. Right ventricular-left ventricular (RV-LV) interaction after repair of tetralogy of Fallot. (A, B) Correlations between RV volume and LV EF. (C) 
Correlation between RV and LV EF. RVEDVi, right ventricular end-diastolic volume index; RVESVi, right ventricular end-systolic volume index; LV EF, left 
ventricular ejection fraction; RV EF, right ventricular ejection fraction. Adapted from Yoo et al. J Thorac Cardiovasc Surg 2012;143:1299-304
10).
Fig. 3. The pathophysiology and influencing factors on right ventricular 
(RV) deterioration from chronic pulmonary regurgitation (PR) after repair 
of tetralogy of Fallot (TOF)
15). RBBB, right bundle branch block; RVEDVi, 
right ventricular end-diastolic volume index; RVOT, right ventricular 
outflow tract; VT, ventricular tachycardia.  http://dx.doi.org/10.3345/kjp.2013.56.6.235
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CMR measures the average antegrade diastolic flow through 
many respiratory cycles, while Doppler echocardiography 
demonstrates the presence of that flow throughout all the 
respiratory cycles. Future studies comparing the differences 
between both methods are needed in order to determine the 
impact of restrictive RV physiology.
Although controversy regarding the risk factors and patho-
physiology of chronic PR still exists, a better understanding of 
the RV mechanics after repair of TOF will help us to optimize 
management strategies. 
PR: how much PR is tolerable and for how long is 
PR tolerable? 
Similar to the natural course of severe AR, it is considered 
that irreversible myocardial damage may develop in the right 
ventricle after a period of reversible dysfunction. On the other 
hand, early PVR to prevent irreversible RV deterio ration 
frequently requires reintervention due to failure of the implanted 
valve. Regarding morbidity and mortality, studies have shown 
that exercise performance might improve after PVR, but it is not 
affected with the degree of pre-PVR ventricular remodeling
32-34). 
Another study showed that PVR for symptomatic RV dilation 
did not reduce the incidence of ventricular tachycardia or 
death
35). These results raise the following question: when should 
PVR be performed?
Although there are no definitive data to make a decision, 
several studies have revealed the pre-PVR threshold of RV 
parameters for the normalization of RV volume and function 
after PVR. The values of threshold showed some difference in 
individual studies; however, it is known that RV deterioration 
Table 1. Indications for pulmonary valve replacement (PVR) in patients with repaired tetralogy of Fallot (TOF) or similar physiology with moderate or 
severe pulmonary regurgitation (regurgitation fraction ≥25%)
15)
I. Asymptomatic patient: ≥2 of the following criteria.
a. RV EDVI >150 mL/m
2 or z score  >4 (in patients whose BSA falls outside normal data: RV/LV EDV ratio >2)
b. RV ESVI >80 mL/m
2
c. RV EF <47%
d. LV EF <55%
e. Large RVOT aneurysm
f . QRS duration >140 ms
g. Sustained tachyarrhythmia (related to right heart volume load)
h. Other hemodynamically abnormalities:
-RVOT obstruction (RV systolic pressure ≥2/3 systemic pressure)
-Severe branch pulmonary artery stenosis (<30% flow to affected lung) 
- ≥ Moderate tricuspid regurgitation
-Left-to-right shunt (from residual ASD or VSD, Qp/Qs ≥1.5)
-Severe aortic regurgitation
-Severe aortic dilatation (diameter ≥5 cm)
II. Symptomatic patients: severe RV volume load documented by CMR or alternative imaging modality: ≥1 of the quantitative criteria in section I
 Examples of symptoms and signs include
a. Exercise intolerance documented by exercise testing with metabolic cart (≤70% predicted peak VO2 for age and gender, not explained by
    chronotropic incompetence)
b. Signs and symptoms of heart failure  
c. Syncope attributable to arrhythmia
III. Special considerations: higher risk of adverse clinical outcomes.
a. TOF repair at age ≥3 yr: ≥1 of the quantitative criteria in section I
b. Pregnant women with severe PR and RV dilatation and/or dysfunction: may be considered if fulfilling ≥1 of the quantitative criteria in section I 
   (no evidence is available to support benefit from prepregnancy PVR)
RV, right ventricular; EDVI, end-diastolic volume index; BSA, body surface area; EDV, end-diastolic volume; LV, left ventricular; ESVI, end-systolic volume 
index; EF, ejection fraction; RVOT, right ventricular outflow tract; ASD, atrial septal defect; VSD, ventricular septal defect; Qp/Qs, pulmonary-to-systemic 
flow ratio; CMR, cardiac magnetic resonance; PR, pulmonary regurgitation.239 http://dx.doi.org/10.3345/kjp.2013.56.6.235
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beyond a certain threshold cannot be recovered after PVR. 
The threshold values identified in each study are as follows: 
Therrien et al.
36), RV end-diastolic volume index (RVEDVi) ≤170 
mL/m
2; Oosterhof et al.
37), RVEDVi <160 mL/m
2 and RV end-
systolic volume index (RVESVi) <82 mL/m
2; Buechel et al.
38), 
RVEDVi <150 mL/m
2; Frigiola et al.
34), RV/LV ratio >2; Lee 
et al.
39), RVEDVi ≤163 mL/m
2 and RVESVi ≤80 mL/m
2; and 
Geva et al.
40), RVEDVi <150 mL/m
2 and RVESVi <90 mL/m
2. 
Similarly, our hospital data presented at the World Congress of 
Pediatric Cardiology and Cardiac Surgery (Cairns, Australia) in 
2009 showed that patients with severe RV deterioration (i.e., 
RVEDVi ≥180 mL/m
2, RVESVi ≥90 mL/m
2, RV EF ≤40%, and 
QRS duration ≥170 ms) could not fully recover their RV volume 
to a normal value (RVEDVi ≤110 mL/m
2 and RVESVi ≤55 mL/
m
2) after PVR.
Based on the results to date, Geva
15) recently recommended 
indications for PVR (Table 1). As shown in this recommendation, 
PVR in symptomatic patients is generally accepted; however, 
the indication for asymptomatic patients, which is the major 
concern, has not been clearly established. In addition, the late 
outcome of PVR after TOF repair is necessary for us to balance 
this indication between the benefits of the elimination of RV 
volume load and the disadvantages of frequent reinterventions. 
PS: does it only have detrimental effect on RV 
mechanics after TOF repair?
Because a previous study showed that residual RVOT 
obstruction was related with early postoperative mortality
41), 
there was no doubt that PS must be completely removed during 
total repair of TOF. During the last 2 decades, while it was 
revealed that PR has been related to the most severe adverse 
outcomes at late follow-up, residual branch pulmonary artery 
stenosis has been recognized to have an adverse effect on RV 
deterioration caused by PR based on a report showing that 
transient balloon occlusion of the unilateral branch pulmonary 
artery increased PR
42).
However, when we attempt the various modified techniques 
of RVOT enlargement in order to limit PR, we are faced with the 
distress that it is not possible to eliminate both PS and PR using 
an ideal technique. Even, a technique that gets rid of all PS 
and PR is referred to the ‘Holy Grail’. However, we found some 
results that were reassuring. In an animal study, PR combined 
with PS was associated with enhanced RV myocardial 
contractility and decreased RV diastolic compliance
43) in marked 
contrast to the data in an isolated PR model
44). Additionally, 
in our clinical experience, patients with PS in addition to PR 
(PS+PR) have been able to tolerate chronic PR better than 
those with isolated PR. This finding was demonstrated in our 
recent study
10). In our study, the pressure gradient of PS in the 
PS+PR group was closely correlated with a smaller PR fraction 
and smaller RV volume indexes even though there was no 
difference in the PR fraction, the transannular patch ratio, or the 
frequency of restrictive physiology between the PS+PR group 
and the isolated PR group (Fig. 4)
10). In multivariate analysis, 
the pressure gradient of PS and PR fraction were revealed as 
definite predictors of RV volume and function in these patients. 
Furthermore, a recent report on percutaneous pulmonary valve 
implantation (PPVI) in patients with PS and/or PR revealed 
that both ventricular responses to exercise in the PS and/or PR 
group showed superior improvement after PPVI, while those in 
the isolated PR group did not improve at all
45).
Based on the results of the previously mentioned animal 
model
43) and our study, it is suggested that PS in addition to PR 
makes RV diastolic property to protect against RV dilatation 
through the RV hypertrophy. These results support the fact 
that RV diastolic compliance has an important role in limiting 
RV dilatation from PR and indicate why we should choose 
conservative RVOT enlargement strategies despite residual PS. 
Although the question of how much PS is acceptable remains 
unanswered, we know that a proper relief of RVOT obstruction 
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Fig. 4. The impact of pressure load on right ventricular (RV) volume and function. Correlations between the peak pressure gradient of pulmonary 
stenosis and (A) pulmonary regurgitation fraction (%), (B) RV end-diastolic volume indexes (RVEDVi), (C) RV end-systolic volume indexes (RVESVi). 
Adapted from Yoo et al. J Thorac Cardiovasc Surg 2012;143:1299-304
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with acceptable residual stenosis is more advantageous than 
aggressive RVOT enlargement in the long-term outcome of 
patients with repaired TOF.
Conclusions
The repair of TOF, which we believed is the most successful 
story in surgery for congenital heart disease, faced a remarkable 
turning point, because the complex pathophysiology of residual 
PS and PR made us regard PR as a benign consequence. Based 
on the studies to date, the conservative RVOT enlargement and 
valve-sparing technique, even at the expense of residual PS, is 
reasonable to prevent RV deterioration from chronic PR in late 
follow-up. 
If studies on patients with repaired TOF continue, better 
understanding of RV mechanics after TOF repair, development 
of new surgical and interventional techniques, and evidence for 
the effect of PVR on RV reverse remodeling and its late outcome 
will aid us to optimize the management of TOF. 
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